JP2012519207A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012519207A5 JP2012519207A5 JP2011552515A JP2011552515A JP2012519207A5 JP 2012519207 A5 JP2012519207 A5 JP 2012519207A5 JP 2011552515 A JP2011552515 A JP 2011552515A JP 2011552515 A JP2011552515 A JP 2011552515A JP 2012519207 A5 JP2012519207 A5 JP 2012519207A5
- Authority
- JP
- Japan
- Prior art keywords
- lenalidomide
- nitro
- solvent system
- piperidine
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN383KO2009 | 2009-03-02 | ||
| IN383/KOL/2009 | 2009-03-02 | ||
| IN463/KOL/2009 | 2009-03-16 | ||
| IN463KO2009 | 2009-03-16 | ||
| PCT/GB2010/050352 WO2010100476A2 (en) | 2009-03-02 | 2010-03-01 | Improved process |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012519207A JP2012519207A (ja) | 2012-08-23 |
| JP2012519207A5 true JP2012519207A5 (enExample) | 2013-04-18 |
| JP5727944B2 JP5727944B2 (ja) | 2015-06-03 |
Family
ID=54290149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011552515A Expired - Fee Related JP5727944B2 (ja) | 2009-03-02 | 2010-03-01 | 改良プロセス |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8946265B2 (enExample) |
| EP (1) | EP2403845B1 (enExample) |
| JP (1) | JP5727944B2 (enExample) |
| CN (1) | CN102414196A (enExample) |
| AU (1) | AU2010220204B2 (enExample) |
| CA (1) | CA2753241C (enExample) |
| CY (1) | CY1115376T1 (enExample) |
| DK (1) | DK2403845T3 (enExample) |
| ES (1) | ES2487215T3 (enExample) |
| HR (1) | HRP20140686T1 (enExample) |
| NZ (1) | NZ595492A (enExample) |
| PL (1) | PL2403845T3 (enExample) |
| PT (1) | PT2403845E (enExample) |
| SI (1) | SI2403845T1 (enExample) |
| SM (1) | SMT201400100B (enExample) |
| WO (1) | WO2010100476A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA83504C2 (en) | 2003-09-04 | 2008-07-25 | Селджин Корпорейшн | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| TWI475014B (zh) * | 2009-09-17 | 2015-03-01 | Scinopharm Taiwan Ltd | 固體形態的３－（４－胺基－１－側氧基－１，３－二氫－異吲哚－２－基）－哌啶－２，６－二酮及其製造方法 |
| WO2011064574A1 (en) | 2009-11-24 | 2011-06-03 | Generics [Uk] Limited | Hplc method for detecting lenalidomide |
| ES2727705T3 (es) | 2010-03-08 | 2019-10-18 | Natco Pharma Ltd | Forma I de lenalidomida anhidra |
| MX352824B (es) | 2010-06-16 | 2017-12-11 | Inflammatory Response Res Inc | Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado común e inflamación. |
| WO2013005229A1 (en) * | 2011-07-05 | 2013-01-10 | Hetero Research Foundation | Process for lenalidomide |
| WO2013012485A2 (en) | 2011-07-19 | 2013-01-24 | Amplio Pharma, Llc | Novel crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| CN102838586A (zh) * | 2012-09-20 | 2012-12-26 | 重庆泰濠制药有限公司 | 一种制备来那度胺的方法 |
| RU2015134423A (ru) | 2013-03-13 | 2017-04-26 | Инфламматори Респонс Ресёрч, Инк. | Применение левоцитиризина и монтелукаста при лечении аутоиммуных расстройств |
| EP2968309A4 (en) | 2013-03-13 | 2016-08-31 | Inflammatory Response Res Inc | USE OF LEVOCETRIXIN AND MONTELUKAST IN THE TREATMENT OF VASCULARITY |
| AU2014249531B2 (en) | 2013-03-13 | 2018-11-29 | IRR, Inc. | Use of levocetirizine and montelukast in the treatment of traumatic injury |
| US9808450B2 (en) | 2013-03-26 | 2017-11-07 | Celgene Corporation | Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof |
| CN103601717A (zh) * | 2013-10-09 | 2014-02-26 | 湖南华腾制药有限公司 | 一种来那度胺的新型制备方法 |
| LV14985B (lv) | 2013-10-14 | 2015-06-20 | Latvijas Organiskās Sintēzes Institūts | Lenalidomīda iegūšanas process |
| US20170107193A1 (en) * | 2014-04-26 | 2017-04-20 | Shilpa Medicare Limited | Crystalline lenalidomide process |
| US10392364B2 (en) | 2014-08-11 | 2019-08-27 | Avra Laboratories Pvt. Ltd. | Process for synthesis of lenalidomide |
| WO2016026785A1 (en) * | 2014-08-19 | 2016-02-25 | Synthon B.V. | Process for making crystalline form a of lenalidomide |
| WO2016044095A1 (en) | 2014-09-15 | 2016-03-24 | Inflammatory Response Research, Inc. | Levocetirizine and montelukast in the treatment of inflammation mediated conditions |
| EP3393457A1 (en) * | 2015-12-22 | 2018-10-31 | Synthon B.V. | Pharmaceutical composition comprising amorphous lenalidomide and an antioxidant |
| US10899793B2 (en) | 2016-05-27 | 2021-01-26 | Regents Of The University Of Minnesota | Melanocortin ligands and methods of use thereof |
| US11124541B2 (en) | 2016-10-18 | 2021-09-21 | Regents Of The University Of Minnesota | Chimeric melanocortin ligands and methods of use thereof |
| JP2020535192A (ja) * | 2017-09-27 | 2020-12-03 | バイオコン・リミテッド | レナリドミドの結晶形 |
| US11452722B2 (en) | 2018-01-11 | 2022-09-27 | Natco Pharma Limited | Stable pharmaceutical compositions comprising lenalidomide |
| US11332499B2 (en) | 2018-08-16 | 2022-05-17 | Regents Of The University Of Minnesota | Cyclic peptides and methods of use thereof |
| CN111196800B (zh) * | 2018-11-19 | 2022-10-11 | 欣凯医药化工中间体（上海）有限公司 | 一种制备来那度胺的方法 |
| WO2021236518A1 (en) | 2020-05-19 | 2021-11-25 | IRR, Inc. | Levocetirizine and montelukast in the treatment of sepsis and symptoms thereof |
| WO2022144924A1 (en) * | 2021-01-04 | 2022-07-07 | Avra Laboratories Pvt. Ltd. | An improved process for synthesis of lenalidomide |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6281230B1 (en) * | 1996-07-24 | 2001-08-28 | Celgene Corporation | Isoindolines, method of use, and pharmaceutical compositions |
| US5635517B1 (en) | 1996-07-24 | 1999-06-29 | Celgene Corp | Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines |
| UA83504C2 (en) | 2003-09-04 | 2008-07-25 | Селджин Корпорейшн | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| ES2437592T3 (es) | 2004-09-03 | 2014-01-13 | Celgene Corporation | Procedimientos para la preparación de 2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolinas sustituidas |
| AU2008240078B2 (en) | 2007-04-16 | 2012-10-25 | Momenta Pharmaceuticals, Inc. | Multi-dimensional chromatographic methods for separating N-glycans |
| AU2008337304A1 (en) | 2007-12-14 | 2009-06-25 | Generics [Uk] Limited | HPLC method for analysing clopidogrel |
| AU2009223014A1 (en) | 2008-03-11 | 2009-09-17 | Dr. Reddy's Laboratories Ltd. | Preparation of lenalidomide |
| US20110263649A1 (en) | 2008-11-03 | 2011-10-27 | Generics [Uk] Limited | Crystalline form of lenalidomide and a process for its preparation |
| WO2011064574A1 (en) | 2009-11-24 | 2011-06-03 | Generics [Uk] Limited | Hplc method for detecting lenalidomide |
-
2010
- 2010-03-01 US US13/254,249 patent/US8946265B2/en active Active
- 2010-03-01 NZ NZ595492A patent/NZ595492A/xx not_active IP Right Cessation
- 2010-03-01 WO PCT/GB2010/050352 patent/WO2010100476A2/en not_active Ceased
- 2010-03-01 JP JP2011552515A patent/JP5727944B2/ja not_active Expired - Fee Related
- 2010-03-01 CA CA2753241A patent/CA2753241C/en active Active
- 2010-03-01 HR HRP20140686AT patent/HRP20140686T1/hr unknown
- 2010-03-01 AU AU2010220204A patent/AU2010220204B2/en not_active Ceased
- 2010-03-01 ES ES10707950.1T patent/ES2487215T3/es active Active
- 2010-03-01 EP EP10707950.1A patent/EP2403845B1/en active Active
- 2010-03-01 PL PL10707950T patent/PL2403845T3/pl unknown
- 2010-03-01 SI SI201030679T patent/SI2403845T1/sl unknown
- 2010-03-01 PT PT107079501T patent/PT2403845E/pt unknown
- 2010-03-01 CN CN2010800195527A patent/CN102414196A/zh active Pending
- 2010-03-01 DK DK10707950.1T patent/DK2403845T3/da active
-
2014
- 2014-07-24 CY CY20141100562T patent/CY1115376T1/el unknown
- 2014-07-28 SM SM201400100T patent/SMT201400100B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101253163B (zh) | 4-氨基-2-(2,6-二氧哌啶-3-基)异吲哚啉-1,3-二酮化合物的制备方法 | |
| JP5426693B2 (ja) | アゴメラチンハロゲン化水素複合体及びその製造方法 | |
| EP2305667A2 (en) | Nilotinib intermediates and preparation thereof | |
| US20120071509A1 (en) | process | |
| JP2016512824A5 (enExample) | ||
| JP2009542785A5 (enExample) | ||
| JP5373996B2 (ja) | サクサグリプチン中間体、サクサグリプチン多形及びそれらの調製方法 | |
| US20110028508A1 (en) | Novel process for the preparation of scopine esters | |
| WO2015163447A1 (ja) | ４環性化合物の新規結晶 | |
| CN102869650B (zh) | 一种厄洛替尼碱的新晶型及其制备方法 | |
| CN110891947B (zh) | 制备艾乐替尼或其药学上可接受的盐的方法 | |
| US10392364B2 (en) | Process for synthesis of lenalidomide | |
| CN111315722B (zh) | 制备月桂酰阿立哌唑的方法 | |
| US9850267B2 (en) | Crystalline fosaprepitant dicyclohexylamine salt and its preparation | |
| JP2022060192A5 (enExample) | ||
| CN103497175A (zh) | 制备来那度胺的方法 | |
| KR101032600B1 (ko) | 고순도 레바미피드의 제조방법 | |
| WO2020053795A2 (en) | Process for the preparation of acalabrutinib and its intermediates | |
| CN103298795A (zh) | 用于制备来曲唑的纯中间体 | |
| WO2014188445A1 (en) | PROCESS FOR THE PREPARATION OF (3β)-17-(3-PYRIDINYL)ANDROSTA-5,16-DIEN-3-YL ACETATE AND POLYMORPH THEREOF | |
| CN111808172B (zh) | 肺念菌素b0衍生物及其制备方法和用途 | |
| EP3679030B1 (en) | A process for preparation of triaminopyrimidine compound and intermediates thereof | |
| CN101029045A (zh) | 一种制备4－(3－吡啶基)－1h－咪唑－1－丁胺的方法 | |
| CN106279112A (zh) | 一种克里唑替尼中间体及其制备方法和应用 | |
| WO2018021517A1 (ja) | ４－アルコキシ－３－トリフルオロメチルベンジルアルコールの製造方法 |